Monochromatic excimer light versus combination of topical steroid with vitamin D3 analogue in the treatment of nonsegmental vitiligo: a randomized blinded comparative study

  title={Monochromatic excimer light versus combination of topical steroid with vitamin D3 analogue in the treatment of nonsegmental vitiligo: a randomized blinded comparative study},
  author={Azmy Ahmed Abdel Latif and Shady Mahmoud Attia Ibrahim},
  journal={Dermatologic Therapy},
Vitiligo is a difficult disease to treat, socially stigmatizing its patients. Monochromatic excimer light (MEL) was developed for use in dermatology and adapted for the treatment of vitiligo. Comparing the efficacy of MEL versus topical combination therapy of vitamin D3 analogue and steroid in the treatment of nonsegmental vitiligo. Forty‐four patients with localized and stable nonsegmental vitiligo participated in the present study. In each patient, two lesions were selected and divided… 
7 Citations
A comparative study on the use of fractional CO2 laser with tacrolimus or calcipotriol or narrow band ultraviolet‐B in treatment of stable nonsegmental vitiligo
Conventional methods of treatment for vitiligo are often unsatisfactory to the patients and time consuming, new treatment modalities are needed. This study was conducted to evaluate the efficacy and
Lasers in the Treatment of Vitiligo
Laser treatment as an alternative treatment modality in vitiligo may help to raise patient compliance and reduce potential risk for skin cancer, its convenience is limited by high cost and accessibility.
A preliminary study of fractional CO2 laser added to topical tacrolimus combined with 308 nm excimer lamp for refractory vitiligo
Overall the triple combination therapy was not superior to tacrolimus ointment plus 308 nm excimer lamp, and treatment failure may reflect insufficient penetration through the holes created by fractional CO2 laser on the skin.
Evaluation of the efficacy of transdermal drug delivery of calcipotriol plus betamethasone versus tacrolimus in the treatment of vitiligo
Microneedling is an evolving treatment technique for an expanding number of dermatologic conditions and is used also to augment transdermal drug delivery through pores created in the stratum corneum.
Recent Advances in Pathogenesis and Medical Management of Vitiligo
The unravelling of interferon (IFN)-γ/CXCL10 axis in the causation of melanocyte directed attack and the observation of clinical usefulness of tofacitinib, which blocks the same pathway, give new hope in the direction of targeted therapy in vitiligo.
Vitiligo and Leukodermas
Although most dermatoses inducing changes of the content and distribution of melanin discoloring the skin are not life-threatening, they have a tremendous psychological and socioeconomic impact among


Monochromatic excimer light 308 nm in monotherapy and combined with topical khellin 4% in the treatment of vitiligo: a controlled study
MEL 308 nm, alone and/or combined with khellin 4% offered encouraging results and it may be considered a valid therapeutic option worthy of consideration in the treatment of vitiligo.
Using a 308-nm excimer laser to treat vitiligo in Asians.
The use of the 308-nm excimer laser for the treatment of vitiligo is effective, relatively safe, and more convenient compared to other available modalities of treatment for stable vitiliga with small patches, however, the therapeutic effect is mainly dependent on the location of Vitiligo lesions.
Combination of PUVAsol and Topical Calcipotriol in Vitiligo
The combination of PUVA and calcipotriol is highly effective and works faster and may be used for shortening the therapy with PUVA in the treatment of vitiligo.
A review of monochromatic excimer light in vitiligo
Monochromatic excimer light (MEL) administered by both laser and lamp has shown efficacy superior to NB‐UVB for the treatment of vitiligo and induces more changes at the cellular level than conventional UVB modalities.
Narrow Band-Ultraviolet B Versus Clobetasol Propionate Foam in the Treatment of Vitiligo: A Retrospective Study
The data showed that CPF is effective and seems to be superior to NB-UVB phototherapy, with furthermore a good safety profile, and this new foam formulation of clobetasol propionate may expand the options currently available for vitiligo therapy.
Topical 0.05% clobetasol propionate versus 1% pimecrolimus ointment in vitiligo.
Results from this pilot study indicate that topical 1% pimecrolimus is as effective as clobetasol propionate in restoring skin disfiguring due to vitiligo.
Topical pimecrolimus in the treatment of vitiligo.
An open pilot study to evaluate the efficacy and safety of 1% pimecrolimus in the treatment of vitiliginous lesions in the head and neck region found side effects were mainly limited to a burning sensation at the application site.
A pilot study to determine the safety and efficacy of monochromatic excimer light in the treatment of vitiligo.
The 308-nm Excilite mu is a safe and fast-acting therapeutic option in patients with stable vitiligo and skin types 3 through 6.
Comparative efficacy and safety of the combination of betamethasone dipropionate and calcipotriene with topical betamethasone dipropionate and calcipotriene alone in the treatment of localized vitiligo
Both the drugs, calcipotriol and betamethasone dipropionate when used individually as monotherapy, were found to be equally effective in the treatment of vitiligo, but the combination of the two was found to been superior in efficacy.
Once-daily application of calcipotriene 0.005%-betamethasone dipropionate 0.064% ointment for repigmentation of facial vitiligo.
Combination calcipotriene 0.005%-betamethasone dipropionate 0.064% ointment shows promise as a once-daily vitiligo therapy and children may experience a better response, but larger studies are needed.